Trial Profile
Phase 2 Double-blind Study of S-525606 in Patients with Japanese Cedar Pollinosis Using an Pollen Challenge Chamber
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs S 525606 (Primary)
- Indications Plant pollen hypersensitivity; Seasonal allergic rhinitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Shionogi
- 14 Oct 2015 New trial record